Published in J Acquir Immune Defic Syndr on February 01, 2001
The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol (2005) 1.76
Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance. J Gen Intern Med (2004) 1.16
Modelling sexual transmission of HIV: testing the assumptions, validating the predictions. Curr Opin HIV AIDS (2010) 1.01
A model for allocating CDC's HIV prevention resources in the United States. Health Care Manag Sci (2010) 1.01
Adherence to antiretroviral HIV drugs: how many doses can you miss before resistance emerges? Proc Biol Sci (2006) 0.97
Modelling imperfect adherence to HIV induction therapy. BMC Infect Dis (2010) 0.94
Modeling HIV transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapy. AIDS Care (2007) 0.92
Mathematical models for the study of HIV spread and control amongst men who have sex with men. Eur J Epidemiol (2011) 0.84
What do mathematical models tell us about the emergence and spread of drug-resistant HIV? Curr Opin HIV AIDS (2011) 0.82
HIV treatment as prevention: contradictory perspectives from dynamic mathematical models. ScientificWorldJournal (2014) 0.75
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 3.86
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67
Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med (1985) 2.62
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med (1993) 2.54
Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. N Engl J Med (1986) 2.40
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis (2012) 2.03
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
A circulation theory of needle exchange. AIDS (1994) 1.58
The era of adherence to HIV therapy. Ann Intern Med (1998) 1.55
The epidemiological and economic consequences of AIDS clinical trials. J Acquir Immune Defic Syndr (1993) 1.47
Criteria for the diagnosis of infective endocarditis. Clin Infect Dis (1994) 1.44
Tuberculosis infection control in rural South Africa: survey of knowledge, attitude and practice in hospital staff. J Hosp Infect (2011) 1.44
Low occupational risk of human immunodeficiency virus infection among dental professionals. N Engl J Med (1988) 1.43
New approaches to HIV surveillance: means and ends. Summary report of conference held at Yale University, 21-22 May 1998, by the Law, Policy and Ethics Core, Center for Interdisciplinary Research on AIDS, Yale University. AIDS Public Policy J (1999) 1.43
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40
The cost-effectiveness of HIV testing: accounting for differential participation rates. Med Decis Making (1997) 1.39
Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis (2012) 1.37
Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1990) 1.36
In vivo antagonism with zidovudine plus stavudine combination therapy. J Infect Dis (2000) 1.30
The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med (1985) 1.29
Early treatment for HIV: the time has come. N Engl J Med (1990) 1.24
Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol (1987) 1.23
Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone. AIDS (1999) 1.15
Economic analysis of needle exchange. AIDS (1995) 1.14
Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys (1996) 1.14
Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users. J Infect Dis (1992) 1.12
Mediastinitis after cardiovascular surgery. Rev Infect Dis (1983) 1.11
Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med (1983) 1.10
Selection bias in in vitro fertilization programs. Am J Obstet Gynecol (1992) 1.10
Drug use in adolescents. Psychodynamic meaning and pharmacogenic effect. Psychoanal Study Child (1969) 1.05
Incubation period of human immunodeficiency virus. Epidemiol Rev (1993) 1.05
Complications of intravenous therapy with steel needles and Teflon catheters. A comparative study. Am J Med (1981) 1.04
A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. Am J Public Health (1996) 1.02
Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT. Radiology (1992) 1.01
Characteristics of HIV-1-associated Kaposi's sarcoma among women and men in South Africa. Int J STD AIDS (2008) 0.99
Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study. J Clin Oncol (1987) 0.98
'Dropouts' or 'drop-ins'? Client retention and participation in New Haven's needle exchange program. Public Health Rep (1995) 0.95
Tuberculosis infection control in a high drug-resistance setting in rural South Africa: information, motivation, and behavioral skills. J Infect Public Health (2012) 0.95
Acquired immunodeficiency syndrome. Ophthalmic manifestations in ambulatory patients. Ophthalmology (1983) 0.94
Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection. J Acquir Immune Defic Syndr (1992) 0.93
The spectrum of HIV-1-related disease among outpatients in New York City. AIDS (1992) 0.92
Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome. JAMA (1986) 0.91
Abdominal wall actinomycosis associated with an IUD. A case report. J Reprod Med (1985) 0.91
An analysis of the process of human immunodeficiency virus sexual risk behavior change. Epidemiology (1995) 0.91
Inability to predict diagnosis in febrile intravenous drug abusers. Ann Intern Med (1987) 0.87
Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1989) 0.87
Prevalence of HIV-infected syringes during a syringe-exchange program. N Engl J Med (1992) 0.87
The recovery of Mycobacterium avium complex and Mycobacterium tuberculosis from blood specimens of AIDS patients using the nonradiometric BACTEC NR 660 medium. Am J Clin Pathol (1990) 0.85
Modeling zidovudine therapy: a cost-effectiveness analysis. J Acquir Immune Defic Syndr (1991) 0.85
Hepatic disorders in the acquired immune deficiency syndrome: a clinical and pathological study. Am J Gastroenterol (1986) 0.84
Accidental, intravenous infusion of a peanut oil-based medication. J Toxicol Clin Toxicol (1998) 0.84
Interactions between methadone and medications used to treat HIV infection: a review. Mt Sinai J Med (2000) 0.83
Inverted ratio of inducer to suppressor T-lymphocyte subsets in drug abusers with opportunistic infections. Clin Immunol Immunopathol (1982) 0.81
Radioimmunotherapy of patients with cutaneous T-cell lymphoma using an iodine-131-labeled monoclonal antibody: analysis of retreatment following plasmapheresis. J Nucl Med (1988) 0.79
Transmission of human immunodeficiency virus type 1 (HIV-1) by exposure to blood: defining the risk. Ann Intern Med (1990) 0.79
Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101. Exp Hematol (1988) 0.79
Assessment of thromboresistance of intravenous cannulae by 125I-fibrinogen scanning. J Biomed Mater Res (1985) 0.78
Expression of activation antigen on lymphocytes in the acquired immunodeficiency syndrome. Ann Intern Med (1986) 0.78
Methadone and antiretroviral medications, part II. AIDS Clin Care (1999) 0.76
Perioperative use of cefoxitin in primary cesarean section. J Reprod Med (1983) 0.76
Transmission of HIV-1 from one child to another. N Engl J Med (1994) 0.75
A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients. AIDS (1990) 0.75
Methadone and antiretroviral medications, part I. AIDS Clin Care (1999) 0.75
In vitro fertilization patient population on which to base predictive testing? Fertil Steril (1996) 0.75
Portable X-ray fluorescence instruments for the analysis of lead in paints. Public Health Rep (1976) 0.75
To treat or not to treat? Nat Med (1998) 0.75
The husband's role in psychiatric illness associated with childbearing. Psychiatr Q (1969) 0.75
Aging and retirement: a difficult issue for individual psychoanalysts and organized psychoanalysis. Bull Menninger Clin (1997) 0.75
Career change in early adulthood: developmental considerations. Adolesc Psychiatry (1989) 0.75
Inner obstacles to psychoanalysts' retirement: personal, clinical, and theoretical perspectives. Bull Menninger Clin (2000) 0.75
Progress in the treatment of cutaneous T cell lymphomas with radiolabeled monoclonal antibodies. Int J Rad Appl Instrum B (1989) 0.75
AIDS precautions for other high-risk groups? Infect Control (1984) 0.75
Clinical care in the AIDS epidemic. Daedalus (1989) 0.75
Breaking the silence. AIDS Clin Care (2000) 0.75
Adrenocortical function in the acquired immunodeficiency syndrome. Ann Intern Med (1983) 0.75
Congenital absence of the vagina. Psychoanal Q (1970) 0.75
Heterogeneity in patient populations explains differences in in vitro fertilization programs. Fertil Steril (1991) 0.75
Association of baseline neuropsychological function and progression of illness over 4 years in HIV-seropositive individuals. Psychosomatics (1994) 0.75
Implications of psychodynamics for therapy in heroin use: a borderline case. NIDA Res Monogr (1977) 0.75
Staphylococcal outbreak in an intensive care unit--a narrative account of its management. Heart Lung (1979) 0.75
The dilemma of disposition: psychiatric decision making and the college-bound high school senior. Adolesc Psychiatry (1982) 0.75
Types of orgasm in women. A critical review and redefinition. J Am Psychoanal Assoc (1968) 0.75
Another take on when to start and how to succeed. AIDS Clin Care (2001) 0.75
Laboratory markers and the risk of developing HIV-1 disease among injecting drug users. AIDS (1994) 0.75
AIDS education. Science (1988) 0.75
Congenital absence of vagina. Psychiatric aspects of diagnosis and management. N Y State J Med (1968) 0.75
Estramustine affects bone mineral metabolism in metastatic prostate cancer. Cancer (1986) 0.75